Galapagos is a drug discovery company focused on finding new drugs against diseases that affect the joints and bones.
At the end of the first trading day on Euronext, the share price rose by 4.14 % compared to the initial reference price of EUR 7, to close at EUR 7.29 bringing the market capitalisation of Galapagos at 64 722 500 EUR.
On the electronic orderbook, a total of 321 196 shares were traded in Brussels and Amsterdam, together amounting to a turnover of EUR 2 346 675.
The company Galapagos is classified as follows:
The Economic group: 40: non-cyclical consumer goods
The Economic sector: 48: pharmaceuticals & biotechnology
The Economic sub-sector: 482: biotechnology
Galapagos is traded on the NSC platform under the following codes:
Euronext Brussels:
- Stock Code: GLPG
- ISIN Code: BE0003818359
- SVM Code: 3818.35
- Stock Code: GLPGA
- ISIN Code: BE0003818359
- Fonds Code: 35840
